Machiels, J., Gomez-Roca, C., Michot, J., Zamarin, D., Mitchell, T., Catala, G., Eberst, L., Jacob, W., Jegg, A., Cannarile, M. A., Watson, C., Babitzki, G., Korski, K., Klaman, I., Teixeira, P., Hoves, S., Ries, C., Meneses-Lorente, G., Michielin, F., Christen, R., Rüttinger, D., Weisser, M., Delord, J., & Cassier, P. (2020). phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients. Journal for immunotherapy of cancer, 8(2), . http://access.bl.uk/ark:/81055/vdc_100127565076.0x00002e